{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:46:14Z","timestamp":1776386774375,"version":"3.51.2"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,16]]},"DOI":"10.7759\/cureus.107193","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:52:12Z","timestamp":1776383532000},"source":"Crossref","is-referenced-by-count":0,"title":["Hypothesis-Generating Analysis of Four Immunosuppressive Regimens After Simultaneous Pancreas-Kidney Transplantation Using the United States Food and Drug Administration Adverse Event Reporting System"],"prefix":"10.7759","author":[{"given":"Toru","family":"Ogura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiko","family":"Urawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.1597","article-title":"Simultaneous pancreas-kidney transplantation: the role in the treatment of type 1 diabetes and end-stage renal disease","volume":"8","author":"Jiang AT","year":"2014","unstructured":"Jiang AT, BHc, Rowe N, Sener A, Luke P. Simultaneous pancreas-kidney transplantation: the role in the treatment of type 1 diabetes and end-stage renal disease. Can Urol Assoc J. 2014, 8:135-8. 10.5489\/cuaj.1597","journal-title":"Can Urol Assoc J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2022.03.059","article-title":"The 2022 international pancreas transplant registry report-a review","volume":"54","author":"Gruessner AC","year":"2022","unstructured":"Gruessner AC, Gruessner RW. The 2022 international pancreas transplant registry report-a review. Transplant Proc. 2022, 54:1918-43. 10.1016\/j.transproceed.2022.03.059","journal-title":"Transplant Proc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01069.x","article-title":"An evidence-based analysis of simultaneous pancreas-kidney and pancreas transplantation alone","volume":"5","author":"Demartines N","year":"2005","unstructured":"Demartines N, Schiesser M, Clavien PA. An evidence-based analysis of simultaneous pancreas-kidney and pancreas transplantation alone. Am J Transplant. 2005, 5:2688-97. 10.1111\/j.1600-6143.2005.01069.x","journal-title":"Am J Transplant"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2024.12235","article-title":"Infection-related hospitalizations after simultaneous pancreas-kidney transplantation compared to kidney transplantation alone","volume":"37","author":"Grasberger J","year":"2024","unstructured":"Grasberger J, Ortiz F, Ekstrand A, et al.. Infection-related hospitalizations after simultaneous pancreas-kidney transplantation compared to kidney transplantation alone. Transpl Int. 2024, 37:12235. 10.3389\/ti.2024.12235","journal-title":"Transpl Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2174\/1381612826666200430111620","article-title":"Induction and immunosuppressive management of pancreas transplant recipients","volume":"26","author":"Amorese G","year":"2020","unstructured":"Amorese G, Lombardo C, Tudisco A, et al.. Induction and immunosuppressive management of pancreas transplant recipients. Curr Pharm Des. 2020, 26:3425-39. 10.2174\/1381612826666200430111620","journal-title":"Curr Pharm Des"},{"key":"ref6","unstructured":"FDA Adverse Event Reporting System (FAERS) quarterly data. (2025). Accessed. September 29, 2025: https:\/\/fis.fda.gov\/extensions\/FPD-QDE-FAERS\/FPD-QDE-FAERS.html."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2026.102345","article-title":"Impact of everolimus-based immunosuppression on transplant rejection or death in lung transplant recipients using the United States Food and Drug Administration Adverse Event Reporting System","volume":"94","author":"Ogura T","year":"2026","unstructured":"Ogura T, Shiraishi C, Urawa A. Impact of everolimus-based immunosuppression on transplant rejection or death in lung transplant recipients using the United States Food and Drug Administration Adverse Event Reporting System. Transpl Immunol. 2026, 94:102345. 10.1016\/j.trim.2026.102345","journal-title":"Transpl Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-019-0754-4","article-title":"Methods to adjust for multiple comparisons in the analysis and sample size calculation of randomised controlled trials with multiple primary outcomes","volume":"19","author":"Vickerstaff V","year":"2019","unstructured":"Vickerstaff V, Omar RZ, Ambler G. Methods to adjust for multiple comparisons in the analysis and sample size calculation of randomised controlled trials with multiple primary outcomes. BMC Med Res Methodol. 2019, 19:129. 10.1186\/s12874-019-0754-4","journal-title":"BMC Med Res Methodol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222690","article-title":"A method of back-calculating the log odds ratio and standard error of the log odds ratio from the reported group-level risk of disease","volume":"15","author":"Hu D","year":"2020","unstructured":"Hu D, Wang C, O'Connor AM. A method of back-calculating the log odds ratio and standard error of the log odds ratio from the reported group-level risk of disease. PLoS One. 2020, 15:e0222690. 10.1371\/journal.pone.0222690","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14061821","article-title":"Maintenance immunosuppression in kidney transplantation: a review of the current status and future directions","volume":"14","author":"Khan MA","year":"2025","unstructured":"Khan MA, Hanna A, Sridhara S, Chaudhari H, Me HM, Attieh RM, Abu Jawdeh BG. Maintenance immunosuppression in kidney transplantation: a review of the current status and future directions. J Clin Med. 2025, 14:10.3390\/jcm14061821","journal-title":"J Clin Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13121706","article-title":"Adverse drug events after kidney transplantation","volume":"13","author":"Rostaing L","year":"2023","unstructured":"Rostaing L, Jouve T, Terrec F, Malvezzi P, Noble J. Adverse drug events after kidney transplantation\r\n. J Pers Med. 2023, 13:10.3390\/jpm13121706","journal-title":"J Pers Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000446357","article-title":"Gender mainstreaming and transplant surgery","volume":"32","author":"Teegen EM","year":"2016","unstructured":"Teegen EM, Krebs I, Langelotz C, Pratschke J, Rau B. Gender mainstreaming and transplant surgery. Visc Med. 2016, 32:286-9. 10.1159\/000446357","journal-title":"Visc Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12754","article-title":"Pancreas transplantation in older patients is safe, but patient selection is paramount","volume":"29","author":"Scalea JR","year":"2016","unstructured":"Scalea JR, Redfield RR 3rd, Arpali E, Leverson G, Sollinger HW, Kaufman DB, Odorico JS. Pancreas transplantation in older patients is safe, but patient selection is paramount. Transpl Int. 2016, 29:810-8. 10.1111\/tri.12754","journal-title":"Transpl Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/tri.13845","article-title":"Recipient age and outcome after pancreas transplantation: a retrospective dual-center analysis","volume":"34","author":"Messner F","year":"2021","unstructured":"Messner F, Leemkuil M, Yu Y, et al.. Recipient age and outcome after pancreas transplantation: a retrospective dual-center analysis. Transpl Int. 2021, 34:657-68. 10.1111\/tri.13845","journal-title":"Transpl Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199304000-00015","article-title":"Frequency of kidney rejection in diabetic patients undergoing simultaneous kidney and pancreatic islet cell transplantation","volume":"55","author":"Carroll PB","year":"1993","unstructured":"Carroll PB, Ricordi C, Shapiro R, et al.. Frequency of kidney rejection in diabetic patients undergoing simultaneous kidney and pancreatic islet cell transplantation. Transplantation. 1993, 55:761-4; discussion 764-5. 10.1097\/00007890-199304000-00015","journal-title":"Transplantation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/478438-hypothesis-generating-analysis-of-four-immunosuppressive-regimens-after-simultaneous-pancreas-kidney-transplantation-using-the-united-states-food-and-drug-administration-adverse-event-reporting-system","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:52:13Z","timestamp":1776383533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/478438-hypothesis-generating-analysis-of-four-immunosuppressive-regimens-after-simultaneous-pancreas-kidney-transplantation-using-the-united-states-food-and-drug-administration-adverse-event-reporting-system"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.107193","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,16]]}}}